Cornelia Grimmel

919 total citations
16 papers, 777 citations indexed

About

Cornelia Grimmel is a scholar working on Molecular Biology, Oncology and Immunology and Allergy. According to data from OpenAlex, Cornelia Grimmel has authored 16 papers receiving a total of 777 indexed citations (citations by other indexed papers that have themselves been cited), including 9 papers in Molecular Biology, 8 papers in Oncology and 6 papers in Immunology and Allergy. Recurrent topics in Cornelia Grimmel's work include Cell death mechanisms and regulation (4 papers), Cancer-related Molecular Pathways (4 papers) and Allergic Rhinitis and Sensitization (3 papers). Cornelia Grimmel is often cited by papers focused on Cell death mechanisms and regulation (4 papers), Cancer-related Molecular Pathways (4 papers) and Allergic Rhinitis and Sensitization (3 papers). Cornelia Grimmel collaborates with scholars based in Germany, United States and France. Cornelia Grimmel's co-authors include Michael Weller, J. Dichgans, Bettina Wagenknecht, Wilfried Roth, Michael Platten, Christine Wild‐Bode, John C. Reed, Stanisław Krajewski, Wolfgang Wick and Hovsep Melkonyan and has published in prestigious journals such as Journal of Neuroscience, Oncogene and British Journal of Cancer.

In The Last Decade

Cornelia Grimmel

15 papers receiving 762 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Cornelia Grimmel Germany 12 556 161 111 90 83 16 777
Niranjan Yanamandra United States 18 441 0.8× 265 1.6× 265 2.4× 76 0.8× 122 1.5× 28 823
Maribelis Ruiz United States 10 469 0.8× 240 1.5× 150 1.4× 43 0.5× 108 1.3× 11 685
Trevor Price United States 9 340 0.6× 308 1.9× 140 1.3× 86 1.0× 140 1.7× 21 849
Jieyi Wang United States 15 443 0.8× 291 1.8× 342 3.1× 70 0.8× 55 0.7× 29 851
A. Yu. Baryshnikov Russia 16 445 0.8× 186 1.2× 133 1.2× 50 0.6× 90 1.1× 79 704
Fabienne Maurer Switzerland 15 598 1.1× 151 0.9× 147 1.3× 24 0.3× 81 1.0× 24 916
Bharathi Gorantla United States 12 377 0.7× 176 1.1× 269 2.4× 85 0.9× 49 0.6× 14 610
Ignazia Tusa Italy 14 336 0.6× 117 0.7× 114 1.0× 53 0.6× 71 0.9× 30 597
Yoshinari Shinsato Japan 14 284 0.5× 164 1.0× 129 1.2× 75 0.8× 40 0.5× 20 523
Meaghan A. Delaney United States 6 449 0.8× 255 1.6× 140 1.3× 150 1.7× 66 0.8× 7 714

Countries citing papers authored by Cornelia Grimmel

Since Specialization
Citations

This map shows the geographic impact of Cornelia Grimmel's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Cornelia Grimmel with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Cornelia Grimmel more than expected).

Fields of papers citing papers by Cornelia Grimmel

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Cornelia Grimmel. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Cornelia Grimmel. The network helps show where Cornelia Grimmel may publish in the future.

Co-authorship network of co-authors of Cornelia Grimmel

This figure shows the co-authorship network connecting the top 25 collaborators of Cornelia Grimmel. A scholar is included among the top collaborators of Cornelia Grimmel based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Cornelia Grimmel. Cornelia Grimmel is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

16 of 16 papers shown
1.
Sobolewska, Bianka, Cornelia Grimmel, Aikaterini Gatsiou, et al.. (2018). Influence of aflibercept on platelet activation profile. Experimental Eye Research. 175. 166–172. 6 indexed citations
2.
Kosnopfel, Corinna, Tobias Sinnberg, Birgit Sauer, et al.. (2018). YB-1 Expression and Phosphorylation Regulate Tumorigenicity and Invasiveness in Melanoma by Influencing EMT. Molecular Cancer Research. 16(7). 1149–1160. 46 indexed citations
3.
Wölbing, Florian, et al.. (2016). 036 Clinical relevance of birch pollen profilin cross reactivity. Journal of Investigative Dermatology. 136(9). S166–S166. 1 indexed citations
4.
Wölbing, Florian, et al.. (2016). The clinical relevance of birch pollen profilin cross-reactivity in sensitized patients. Allergy. 72(4). 562–569. 18 indexed citations
5.
Sobolewska, Bianka, Cornelia Grimmel, Aikaterini Gatsiou, et al.. (2015). Different Effects of Ranibizumab and Bevacizumab on Platelet Activation Profile. Ophthalmologica. 234(4). 195–210. 12 indexed citations
6.
Kneilling, Manfred, Ulrich M. Caroli, Cornelia Grimmel, et al.. (2010). Para‐phenylenediamine‐specific lymphocyte activation test: a sensitive in vitro assay to detect para‐phenylenediamine sensitization in patients with severe allergic reactions. Experimental Dermatology. 19(5). 435–441. 16 indexed citations
7.
Wick, Wolfgang, Cornelia Grimmel, Christine Wild‐Bode, et al.. (2001). Ezrin-Dependent Promotion of Glioma Cell Clonogenicity, Motility, and Invasion Mediated by BCL-2 and Transforming Growth Factor-β2. Journal of Neuroscience. 21(10). 3360–3368. 75 indexed citations
8.
Roth, Wilfried, Christine Wild‐Bode, Michael Platten, et al.. (2000). Secreted Frizzled-related proteins inhibit motility and promote growth of human malignant glioma cells. Oncogene. 19(37). 4210–4220. 141 indexed citations
9.
Roth, Wilfried, Cornelia Grimmel, Lorenz Rieger, et al.. (2000). Bag‐1 and Bcl‐2 Gene Transfer in Malignant Glioma: Modulation of Cell Cycle Regulation and Apoptosis. Brain Pathology. 10(2). 223–234. 31 indexed citations
10.
Münz, Christian, Ulrike Naumann, Cornelia Grimmel, Hans‐Georg Rammensee, & Michael Weller. (1999). TGF-β-independent induction of immunogenicity by decorin gene transfer in human malignant glioma cells. European Journal of Immunology. 29(3). 1032–1040. 30 indexed citations
11.
Münz, Christian, Ulrike Naumann, Cornelia Grimmel, Hans‐Georg Rammensee, & Michael Weller. (1999). TGF-β-independent induction of immunogenicity by decorin gene transfer in human malignant glioma cells. European Journal of Immunology. 29(3). 1032–1040.
12.
Wick, Wolfgang, Cornelia Grimmel, Bettina Wagenknecht, J. Dichgans, & Michael Weller. (1999). Betulinic Acid-Induced Apoptosis in Glioma Cells: A Sequential Requirement for New Protein Synthesis, Formation of Reactive Oxygen Species, and Caspase Processing. Journal of Pharmacology and Experimental Therapeutics. 289(3). 1306–1312. 125 indexed citations
13.
Weller, Michael, Johannes Rieger, Cornelia Grimmel, et al.. (1998). Predicting chemoresistance in human malignant glioma cells: The role of molecular genetic analyses. International Journal of Cancer. 79(6). 640–644. 152 indexed citations
14.
Weller, Michael, Johannes Rieger, Cornelia Grimmel, et al.. (1998). Predicting chemoresistance in human malignant glioma cells: The role of molecular genetic analyses. International Journal of Cancer. 79(6). 640–644. 9 indexed citations
15.
Roth, Wilfried, Bettina Wagenknecht, Cornelia Grimmel, J. Dichgans, & Michael Weller. (1998). Taxol-mediated augmentation of CD95 ligand-induced apoptosis of human malignant glioma cells: association with bcl-2 phosphorylation but neither activation of p53 nor G2/M cell cycle arrest. British Journal of Cancer. 77(3). 404–411. 52 indexed citations
16.
Weller, Michael, Martin Trepel, Cornelia Grimmel, et al.. (1997). Hypericin-induced apoptosis of human malignant glioma cells is light-dependent, independent of bcl-2 expression, and does not require wild-type p53. Neurological Research. 19(5). 456–470. 63 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026